Cellectis (CLLS) Stock: Buy, Sell, or Hold?
CLLS - Cellectis S.A. American Depositary Shares
$1.43
0.03 (2.14%)
▲
5d:
-2.72%
30d:
-56.0%
90d:
-56.53%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 06, 2026
Get Alerted When CLLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CLLS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CLLS shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CLLS is currently trading at $1.43, which is considered oversold relative to its 30-day fair value range of $1.43 to $3.23.
Technical Outlook: Technically, CLLS is in a strong downtrend. Immediate support is located at $1.36, while resistance sits at $1.62.
Market Sentiment: CLLS scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.33 (+272.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLLS is in a strong downtrend. Immediate support is located at $1.36, while resistance sits at $1.62.
Market Sentiment: CLLS scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.33 (+272.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.43 -
$3.23
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 272.4% below Wall St target ($5.33)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.43 -
$3.23
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.36
Resistance Level
$1.62
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.07
Wall Street Target
$5.33
(+272.4%)
Revenue Growth (YoY)
-62.1%
Profit Margin
-102.3%
Share & Embed Analysis
Last updated: October 03, 2026 10:46 AM ET
Data refreshes hourly during market hours. Next update: 11:46 AM
Data refreshes hourly during market hours. Next update: 11:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLLS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 56 HOLD |
